Picture of Interpace Biosciences logo

IDXG Interpace Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Interpace Biosciences Q1 Revenue USD 11.515 Million

May 08 (Reuters) - Interpace Biosciences Q1 gross profit USD 7.37 million.

Q1 operating expenses USD 5.541 million

Q1 operating income USD 1.829 million

Q1 net income USD 1.647 million

Recent news on Interpace Biosciences

See all news